Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Post

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancerJudit Boda-Heggemann, Ralf-Dieter Hofheinz, Christel Weiss, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based chemoradiotherapy in patients with rectal cancerPhilipp Erben, Karoline Horisberger, Benjamin Muessle, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORITKirsten Merx, Uwe M Martens, Melanie Kripp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 27, 2006
Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantationPeter Schnuelle, Uwe Gottmann, Hannes Köppel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2009
Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trialKaroline Horisberger, Anne Treschl, Sabine Mai, et al.
Molecular Endocrinology (Baltimore, Md.)|April 5, 2012
Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding proteinElke Prade, Moritz Tobiasch, Ivana Hitkova, et al.
Langenbeck'S Archives of Surgery|June 30, 2011
Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study GroupDaniel Palmes, Matthias Brüwer, Franz G Bader, et al.
JAMA|January 18, 2007
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trialHelmut Oettle, Stefan Post, Peter Neuhaus, et al.
BMC Cancer|December 16, 2017
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer societyChristoph Kowalski, Ullrich Graeven, Christof von Kalle, et al.
The Lancet. Oncology|April 17, 2012
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trialRalf-Dieter Hofheinz, Frederik Wenz, Stefan Post, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancerJudit Boda-Heggemann, Ralf-Dieter Hofheinz, Christel Weiss, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based chemoradiotherapy in patients with rectal cancerPhilipp Erben, Karoline Horisberger, Benjamin Muessle, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORITKirsten Merx, Uwe M Martens, Melanie Kripp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 27, 2006
Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantationPeter Schnuelle, Uwe Gottmann, Hannes Köppel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2009
Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trialKaroline Horisberger, Anne Treschl, Sabine Mai, et al.
Molecular Endocrinology (Baltimore, Md.)|April 5, 2012
Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding proteinElke Prade, Moritz Tobiasch, Ivana Hitkova, et al.
Langenbeck'S Archives of Surgery|June 30, 2011
Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study GroupDaniel Palmes, Matthias Brüwer, Franz G Bader, et al.
JAMA|January 18, 2007
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trialHelmut Oettle, Stefan Post, Peter Neuhaus, et al.
BMC Cancer|December 16, 2017
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer societyChristoph Kowalski, Ullrich Graeven, Christof von Kalle, et al.
The Lancet. Oncology|April 17, 2012
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trialRalf-Dieter Hofheinz, Frederik Wenz, Stefan Post, et al.
Pageof 14